Corporate Lobbying on U.S. Positions Toward the World Health Organization

Posted on May 19, 2022 in The Americas, The Americas

This study links corporate lobbying expenditures and coinciding public statements to legislative proposals and other actions to restrict funding to, censure, and undermine confidence in the WHO.
Overall, these findings indicate corporate lobbying not only targets specific WHO processes that conflict with commercial interests, but also works to cast doubt on the integrity and narrow the operational capacities of the global health governance system itself.

Addiction Industries, Big Alcohol, Big Pharma, Big Tobacco, BigAlcoholExposed, Commercial Determinants of Health, Conflict Of Interest, Science
Read full article
Back to top